Protalix Biotherapeutics Inc

Stock Chart, Company Information, and Scan Results

$2.04(as of Oct 20, 12:31 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Protalix Biotherapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.04
Ticker SymbolPLX
ExchangeNyse Mkt
SectorHealthcare
IndustryBiotechnology
Employees213
CountyUSA
Market Cap$148.3M
EBIDTA9.6M
10-Day Moving Average2.42
P/E Ratio24.09
20-Day Moving Average2.29
Forward P/E Ratio4.29
50-Day Moving Average1.91
Earnings per Share0.09
200-Day Moving Average2.04
Profit Margin1.05%
RSI39.23
Shares Outstanding79.7M
ATR0.17
52-Week High3.10
Volume5,501,700
52-Week Low1.01
Most Recent Support Level2.31
Book Value49.9M
Most Recent Resistance Level2.55
P/B Ratio3.03
Upper Keltner2.68
P/S Ratio2.44
Lower Keltner1.90
Debt-to-Equity Ratio2.68
Next Earnings Date11/17/2025
Cash Surplus-6.2M
Next Ex-Dividend DateUnknown

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.

Protalix Biotherapeutics Inc In Our Stock Scanner

As of Oct 20, 2025
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.